HCPCS Level II drug code
J3473 — Injection, hyaluronidase, recombinant, 1 usp unit
In short
J3473 is the HCPCS Level II code for injection, hyaluronidase, recombinant, 1 usp unit. CMS assigns NDCs for Hylenex to it. The Medicare Part B payment limit is $0.364 per unit (October 1, 2026 through December 31, 2026).
Code
CMS HCPCS file- Descriptor
- Injection, hyaluronidase, recombinant, 1 usp unit
- Short descriptor
- Hyaluronidase recombinant
- Code set
- HCPCS Level II, maintained by CMS
- Effective
- Jan 1, 2007
Medicare Part B payment limit
CMS ASP fileEffective October 1, 2026 through December 31, 2026. Payment allowance limits subject to the ASP methodology are based on 2Q26 ASP data. A payment limit is not a coverage decision; the Medicare contractor decides coverage. CMS ASP pricing files
Units and claim line
Enter the dose to get the units and the NDC line for the CMS-1500 and the 837P.
Enter the units to build the claim line.
NDCs billed under J3473
CMS’s ASP NDC–HCPCS crosswalk (effective October 1, 2026 through December 31, 2026) assigns 2 NDCs to J3473 for Hylenex. Billing units per package are CMS’s figures for this code’s unit.
| Drug | NDC (11-digit) | Labeler | Package | Billing units per package |
|---|---|---|---|---|
| Hylenex | 18657-0117-04 | Antares Pharma, Inc. | 4 × 1 | 600 |
| Hylenex | 51662-1555-01 | HF Acquisition Co. LLC, DBA HealthFirst | 1 | 150 |
J3473: common questions
- Is J3473 a CPT code?
- No. J3473 is a HCPCS Level II code, maintained by CMS, that identifies the drug supplied. CPT codes are five-digit numbers from the AMA that describe services. Giving the drug, for example an injection or infusion, is usually reported with a separate CPT administration code. CPT codes for drug administration.
- What NDCs are billed under J3473?
- CMS's ASP crosswalk for October 1, 2026 through December 31, 2026 lists 2 NDCs under J3473, for Hylenex. The table on this page shows each one with its billing units per package.
- What is the Medicare payment limit for J3473?
- $0.364 per 1 usp unit, effective October 1, 2026 through December 31, 2026, from CMS's Part B drug payment limit file. Multiply by the units billed for the allowed amount before deductible and coinsurance. It is not a coverage decision.